Suppression of mediastinal metastasis by uracil-tegafur or cis-diamminedichloroplatinum(II) using a lymphogenous metastatic model in a human lung cancer cell line

Clinical Cancer Research

Volumn 7, Issue 12, 2001, Pages 4202-4208

  Ishikura, H ^a   Kondo, K ^a   Miyoshi, T ^a   Kinoshita, H ^a   Takahashi, Y ^a   Fujino, H ^a   Monden, Y ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; UFT; URACIL;

ARTICLE; CANCER CELL CULTURE; CANCER PATIENT; CANCER SURVIVAL; CYTOSTASIS; DRUG EFFECT; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMPLANTATION; LUNG CANCER; LYMPH NODE METASTASIS; MEDIASTINUM LYMPH NODE; MEDIASTINUM METASTASIS; MODEL; PRIORITY JOURNAL; TUMOR GROWTH;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MICE; MICE, SCID; MODELS, BIOLOGICAL; NEOPLASM METASTASIS; SURVIVAL; TEGAFUR; TIME FACTORS; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; URACIL;

EID: 0035679779     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Revisions in the international system for staging lung cancer
2. Activation of the precursor of gelatinase A/72kDa type collagenase/MMP-2 in lung carcinomas correlates with the expression of membrane-type matrix metalloproteinase (MT-MMP) and with lymph node metastasis
3. Correlation of serum metalloproteinase levels with lung cancer metastasis and response to therapy
4. The expression of the CD44 variant exon 6 is associated with lymph node metastasis in non-small cell lung cancer
5. Expression of CD44 standard form and variant isoforms in non-small cell lung carcinomas
6. Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis
7. Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer
8. SCID mouse lymphogenous metastatic model of human lung cancer constructed using orthotopic inoculation of cancer cell line
9. Artificial lymphogenous metastatic model using orthotopic implantation of human lung cancer
10. Lymph node involvement, recurrence, and prognosis in resected small, peripheral, non-small-cell lung carcinomas: Are these carcinomas candidates for video-assisted lobectomy?
11. Survival and prognostic factors in resected N2 non-small cell lung cancer: A study of 140 cases
12. Irradiated nude rat model for orthotopic human lung cancers
13. A new patient-like metastatic model of human small-cell lung cancer constructed orthotopically with intact tissue via thoracotomy in nude mice
14. Novel intrapulmonary model for orthotopic propagation of human lung cancers in athymic nude mice
15. Comparison of intrapulmonary, percutaneous intrathoracic, and subcutaneous models for the propagation of human pulmonary and nonpulmonary cancer cell lines in athymic nude mice
16. Establishment of an experimental intrapulmonary tumor nodule model
17. A randomized controlled postoperative adjuvant chemotherapy trial of MMC + Tegafur and MMC + UFT for adenocarcinoma of the lung-first study
18. Evaluation of cisplatin intensity in metastatic non-small-cell-lung-cancer: A Phase study of the Southwest Oncology Group
19. Platinum-based polychemotherapy versus dianhydrogalactitol in advanced non-small cell lung cancer
20. Chemotherapy for metastatic non-small-cell bronchogenic carcinoma: EST 2574 generation - A randomized comparison of four cisplatin-containing regimens
21. A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer
22. Adjuvant chemotherapy after complete resection in non-small-cell lung cancer
23. Life prolonging effect of antitumor agents on postoperative adjuvant therapy in the lung spontaneous metastasis model in mice
24. UFT and its metabolites inhibit the angiogenesis induced by murine renal cell carcinoma, as determined by a dorsal air sac assay in mice
25. Chemosensitivity of micrometastases and circulating tumor cells to uracil and tegafur as evaluated using LacZ genetagged Lewis lung carcinoma cell
26. Delay in administration of CDDP until completion of AGM-1470 treatment enhances antimetastatic and antitumor effects
27. A peptide derived from the non-receptor-binding region of urokinase plasminogen activator inhibits glioblastoma growth and angiogenesis in vivo in combination with cisplatin
28. The microtubule-affecting drug paclitaxel has antiangiogenic activity